These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6657726)

  • 1. Inhibition of morphine-induced analgesia and locomotor activity in strains of mice: a comparison of long-acting opiate antagonists.
    Frischknecht HR; Siegfried B; Riggio G; Waser PG
    Pharmacol Biochem Behav; 1983 Dec; 19(6):939-44. PubMed ID: 6657726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of morphine-induced behavioral suppression by opiate receptor alkylators.
    Messing RB; Portoghese PS; Takemori AE; Sparber SB
    Pharmacol Biochem Behav; 1982 Apr; 16(4):621-6. PubMed ID: 6280206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of naloxone and naltrexone on locomotor activity in C57BL/6 and DBA/2 mice.
    Castellano C; Puglisi-Allegra S
    Pharmacol Biochem Behav; 1982 Apr; 16(4):561-3. PubMed ID: 6280203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profiles of beta-funaltrexamine (beta-FNA) and beta-chlornaltrexamine (beta-CNA) on the mouse vas deferens preparation.
    Ward SJ; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1982 Jun; 80(4):377-84. PubMed ID: 6286325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine-6-glucuronide-induced locomotor stimulation in mice: role of opioid receptors.
    Grung M; Skurtveit S; Aasmundstad TA; Handal M; Alkana RL; Mørland J
    Pharmacol Toxicol; 1998 Jan; 82(1):3-10. PubMed ID: 9527644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of naloxonazine and beta-funaltrexamine antagonism of mu 1 and mu 2 opioid actions.
    Pick CG; Paul D; Pasternak GW
    Life Sci; 1991; 48(21):2005-11. PubMed ID: 1851915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
    Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxazone, a long-acting opiate antagonist: effects on analgesia in intact animals and on opiate receptor binding in vitro.
    Pasternak GW; Childers SR; Snyder SH
    J Pharmacol Exp Ther; 1980 Sep; 214(3):455-62. PubMed ID: 6105201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of morphine on locomotor activity, analgesia and primary and protracted physical dependence in six mouse strains.
    Brase DA; Loh HH; Way EL
    J Pharmacol Exp Ther; 1977 May; 201(2):368-74. PubMed ID: 558328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic dissociation of multiple morphine effects among C57BL/6J, DBA/2J and C3H/HeJ inbred mouse strains.
    Belknap JK; Noordewier B; Lamé M
    Physiol Behav; 1989 Jul; 46(1):69-74. PubMed ID: 2813556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the interaction of morphine with kappa and delta opioid receptors to induce analgesia in beta-funaltrexamine-treated mice.
    Takemori AE; Portoghese PS
    J Pharmacol Exp Ther; 1987 Oct; 243(1):91-4. PubMed ID: 2822908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.
    Gistrak MA; Paul D; Hahn EF; Pasternak GW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):469-76. PubMed ID: 2553921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite effects of restraint on morphine analgesia and naloxone-induced jumping.
    Dymshitz J; Amir S
    Pharmacol Biochem Behav; 1988 Aug; 30(4):905-10. PubMed ID: 3227039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains.
    Pick CG; Nejat RJ; Pasternak GW
    J Pharmacol Exp Ther; 1993 Apr; 265(1):166-71. PubMed ID: 8386234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of beta-funaltrexamine in normal and morphine-dependent rhesus monkeys: observational studies.
    Gmerek DE; Woods JH
    J Pharmacol Exp Ther; 1985 Nov; 235(2):296-301. PubMed ID: 4057071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological studies with an alkylating narcotic agonist, chloroxymorphamine, and antagonist, chlornaltrexamine.
    Caruso TP; Larson DL; Portoghese PS; Takemori AE
    J Pharmacol Exp Ther; 1980 Jun; 213(3):539-44. PubMed ID: 6162947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal beta-funaltrexamine antagonizes intracerebroventricular beta-endorphin- but not morphine-induced analgesia in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1988 May; 245(2):587-93. PubMed ID: 2966856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the antagonistic effects of 6 beta-naltrexol and naltrexone against morphine analgesia].
    Yan LD; Gong ZH; Yao XJ; Qin BY
    Yao Xue Xue Bao; 2003 Aug; 38(8):578-81. PubMed ID: 14628446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of beta-funaltrexamine (beta-FNA) on morphine dependence in rats and monkeys.
    Aceto MD; Dewey WL; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1986 Apr; 123(3):387-93. PubMed ID: 3720824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.